A carregar...
The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic cell transplantation (allo-HCT). Despite the use of prophylactic immunosuppression including calcineurin inhibitors, antimetabolites, antithymocyte globulin, or posttransplant cyclophosphamide,...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7422131/ https://ncbi.nlm.nih.gov/pubmed/32780849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002097 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|